https://www.selleckchem.com/pr....oducts/kb-0742-dihyd
There was no statistically significant difference in complete response rate between the TEA group (84/88 or 95.5%) and the RFA group (188/195 or 96.4%) (p = 0.7). Time to progression in the TEA group [median 11.9 months, interquartile range (IQR) 5.6-18 months] was not statistically different from that in the RFA group (median 9.5 months, IQR 3.5-18.7 months) (p = 0.773). CONCLUSION TEA could be an effective alternative of RFA for the local treatment of small HCC; it is especially valuable for tumors of unfavorable locat
Like
Comment
Share
